Vimarsana
Biggest News Aggregation in the World

Page 27 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Dalata Hotel Group PLC: Director/ PDMR Shareholding - Vimarsana News

Dalata Hotel Group PLC: Director/ PDMR Shareholding

DJ Dalata Hotel Group PLC: Director/ PDMR Shareholding Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Director/ PDMR Shareholding 16-March-2023 / 12:34 GMT/BST -----------------------------------------------------------------------------------------------------------------------

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...

INOVIO Reports Inducement Grants Under Inducement Plan - Vimarsana News

INOVIO Reports Inducement Grants Under Inducement Plan

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.02.2023 - CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2022 that were previously approved by the Compensation ...